These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 29669714)
1. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons. Straiker A; Dvorakova M; Zimmowitch A; Mackie K Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714 [TBL] [Abstract][Full Text] [Related]
2. Differential Enantiomer-Specific Signaling of Cannabidiol at CB Bosquez-Berger T; Wilson S; Iliopoulos-Tsoutsouvas C; Jiang S; Wager-Miller J; Nikas SP; Mackie KP; Makriyannis A; Straiker A Mol Pharmacol; 2022 Dec; 102(6):259-268. PubMed ID: 36153039 [TBL] [Abstract][Full Text] [Related]
3. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model. Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948 [TBL] [Abstract][Full Text] [Related]
4. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
8. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. Fogaça MV; Campos AC; Coelho LD; Duman RS; Guimarães FS Neuropharmacology; 2018 Jun; 135():22-33. PubMed ID: 29510186 [TBL] [Abstract][Full Text] [Related]
9. Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease. Laprairie RB; Bagher AM; Kelly ME; Denovan-Wright EM Mol Pharmacol; 2016 Mar; 89(3):364-75. PubMed ID: 26700564 [TBL] [Abstract][Full Text] [Related]
10. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. McPartland JM; Duncan M; Di Marzo V; Pertwee RG Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
12. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373 [TBL] [Abstract][Full Text] [Related]
13. Metabotropic suppression of excitation in murine autaptic hippocampal neurons. Straiker A; Mackie K J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416 [TBL] [Abstract][Full Text] [Related]
14. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. Ryan D; Drysdale AJ; Pertwee RG; Platt B Eur J Neurosci; 2007 Apr; 25(7):2093-102. PubMed ID: 17419758 [TBL] [Abstract][Full Text] [Related]
15. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Pertwee RG Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291 [TBL] [Abstract][Full Text] [Related]
16. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874 [TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism and Cannabinoid Pharmacology. Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882 [TBL] [Abstract][Full Text] [Related]
18. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211 [TBL] [Abstract][Full Text] [Related]
20. The Cannabinoids Effect on Bone Formation and Bone Healing. Raphael-Mizrahi B; Gabet Y Curr Osteoporos Rep; 2020 Oct; 18(5):433-438. PubMed ID: 32705630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]